Suppr超能文献

比较 Clostripain 和中性蛋白酶作为人胰岛分离的补充酶。

Comparison of Clostripain and Neutral Protease as Supplementary Enzymes for Human Islet Isolation.

机构信息

1 Nuffield Department of Surgical Sciences, University of Oxford, UK.

2 Oxford Centre for Diabetes, Endocrinology and Metabolism, UK.

出版信息

Cell Transplant. 2019 Feb;28(2):176-184. doi: 10.1177/0963689718811614. Epub 2018 Nov 13.

Abstract

Although human islet transplantation has been established as valid and safe treatment for patients with type 1 diabetes, the utilization rates of human pancreases for clinical islet transplantation are still limited and substantially determined by the quality and composition of collagenase blends. While function and integrity of collagenase has been extensively investigated, information is still lacking about the most suitable supplementary neutral proteases. The present study compared islet isolation outcome after pancreas digestion by means of collagenase used alone or supplemented with either neutral protease (NP), clostripain (CP), or both proteases. Decent amounts of islet equivalents (IEQ) were isolated using collagenase alone (3090 ± 550 IEQ/g), or in combination with NP (2340 ± 450 IEQ/g) or CP (2740 ± 280 IEQ/g). Nevertheless, the proportion of undigested tissue was higher after using collagenase alone (21.1 ± 1.1%, P < 0.05) compared with addition of NP (13.3 ± 2.2%) or CP plus NP (13.7 ± 2.6%). Likewise, the percentage of embedded islets was highest using collagenase only (13 ± 2%) and lowest adding NP plus CP (4 ± 1%, P < 0.01). The latter combination resulted in lowest post-culture overall survival (42.7 ± 3.9%), while highest survival was observed after supplementation with CP (74.5 ± 4.8%, P < 0.01). An insulin response toward glucose challenge was present in all experimental groups, but the stimulation index was significantly decreased using collagenase plus NP (2.0 ± 0.12) compared with supplementation with CP (3.16 ± 0.4, P < 0.001). This study demonstrates for the first time that it is possible to isolate significant numbers of human islets combining collagenase only with CP. The supplementation with CP is an effective means to substantially reduce NP activity, which significantly decreases survival and viability after culture. This will facilitate the manufacturing of enzyme blends with less harmful characteristics.

摘要

尽管人胰岛移植已被确立为治疗 1 型糖尿病患者的有效且安全的治疗方法,但用于临床胰岛移植的人胰腺利用率仍然有限,并且主要取决于胶原酶混合物的质量和组成。尽管已经广泛研究了胶原酶的功能和完整性,但有关最合适的补充中性蛋白酶的信息仍然缺乏。本研究比较了单独使用胶原酶或补充中性蛋白酶 (NP)、枯草溶菌素 (CP) 或这两种蛋白酶后胰腺消化的胰岛分离效果。单独使用胶原酶(3090 ± 550IEQ/g)或与 NP(2340 ± 450IEQ/g)或 CP(2740 ± 280IEQ/g)联合使用时,可分离出相当数量的胰岛当量(IEQ)。然而,单独使用胶原酶后未消化组织的比例更高(21.1 ± 1.1%,P < 0.05),与添加 NP(13.3 ± 2.2%)或 CP 加 NP(13.7 ± 2.6%)相比。同样,仅使用胶原酶时包埋胰岛的百分比最高(13 ± 2%),添加 NP 加 CP 时最低(4 ± 1%,P < 0.01)。后一种组合导致培养后整体存活率最低(42.7 ± 3.9%),而添加 CP 时存活率最高(74.5 ± 4.8%,P < 0.01)。所有实验组均存在葡萄糖刺激后的胰岛素反应,但添加 NP 时刺激指数明显降低(2.0 ± 0.12),与添加 CP 时(3.16 ± 0.4,P < 0.001)相比。本研究首次证明,仅使用胶原酶与 CP 联合即可分离大量的人胰岛。CP 的补充是一种有效方法,可以显著降低 NP 活性,从而显著降低培养后的存活率和活力。这将有助于制造具有较少有害特性的酶混合物。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验